Prestige Consumer Healthcare
- Market cap
- 2.25B
- P/E (TTM)i
- 13.32
- P/Bi
- 1.18
- EPSi
- 3.91
- Div yieldi
- 0.00%
- 52W posi
- 17%
Anonymous reader poll. Unscientific, not investment advice.
About Prestige Consumer Healthcare
Prestige Consumer Healthcare, Inc. engages in the marketing, sale, and distribution of pharmaceutical drugs and consumer products. It operates through the North American OTC Healthcare and International OTC Healthcare segments. The North American OTC Healthcare segment consists of BC and Goody's, Boudreaux's Butt Paste, Chloraseptic, Clear Eyes, Compound W, Debrox, DenTek, Dramamine, Efferdent, Fleet, Gaviscon, Luden's, Monistat, Nix, Summer's Eve. The International OTC Healthcare segment includes Fess and Hydralite. The company was founded in 1996 and is headquartered in Tarrytown, NY.
- Founded
- 1996
- CEO
- Mr. Ronald M. Lombardi
- Employees
- 890
- Headquarters
- Tarrytown, New York, United States of America
- Fiscal year end
- 03-31
- Website
- prestigebrands.com
Company profile
- Exchange
- US
- Symbol
- PBH
- Market-cap rank
- #2733
- Listing date
- 1970-01-01
- Market cap
- 2.25B
- Float cap
- 2.22B
- Shares out
- 47.37M
- Float shares
- 46.70M
Sectors & themes
Quote time 2026-10-07 19:54:59 · For reference only, not investment advice and not tailored to your situation.